Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Major Shareholder Announcement
Company Announcement
Major shareholder announcement for Genmab A/S
Copenhagen, Denmark; July 21, 2021 – Genmab A/S (Nasdaq: GMAB) announces under reference to Section 30 of the Danish Capital Markets Act that Artisan Partners Limited Partnership has informed us that, as of July 16, 2021, Artisan Partners Limited Partnership holds the voting rights to 3,261,591 shares in Genmab A/S, which amounts to 4.97% of the share capital and voting rights in Genmab A/S.
About Genmab Genmab is an international biotechnology company with a core purpose to improve the lives of patients with cancer. Founded in 1999, Genmab is the creator of multiple approved antibody therapeutics that are marketed by its partners. The company aims to create, develop and commercialize differentiated therapies by leveraging next-generation antibody technologies, expertise in antibody
Japan
Tokyo
Netherlands
Denmark
Copenhagen
Køavn
New-jersey
United-states
Danish
Kalvebod-brygge
Marisol-peron
Andrew-carlsen